SCHEMBL7746055

SCHEMBL7746055

O=c1c2ccccc2n(Cc2nc3ccccc3n2CCCCO)c(=O)n1C1CC1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.72
TSHR P16473 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPSR1 Q6W5P4 3/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
ALDH1A1 P00352 4/20 0.45
POLB P06746 2/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
CNR2 P34972 1/20 0.40
USP2 O75604 1/20 0.40
RECQL P46063 1/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7745852 0.91 CYP3A4 (0.59) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP
SCHEMBL6274097 0.88 CYP3A4 (0.58) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP
SCHEMBL7741783 0.86 CYP3A4 (0.54) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP
SCHEMBL8366214 0.86 CYP3A4 (0.54) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP
SCHEMBL16696112 0.84 CYP3A4 (0.66) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP
SCHEMBL29413237 0.83 CYP3A4 (1.00) CYP3A4TSHRSMN1; SMN2POLBMEN1
SCHEMBL3822776 0.83 CYP3A4 (1.00) CYP3A4TSHRSMN1; SMN2POLBMEN1
SCHEMBL6479793 0.82 CYP3A4 (0.50) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP
SCHEMBL6783757 0.81 CYP3A4 (0.54) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP
SCHEMBL6245596 0.81 CYP3A4 (0.50) CYP3A4TSHRSMN1; SMN2NPSR1CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed